Please enable JavaScript to continue using this application.

Compare $DWTX vs $HRGN | Chartloom

Compare

$DWTX vs $HRGN

Dogwood Therapeutics Inc · Harvard Apparatus Regenerative Technology Inc

DWTX

Dogwood Therapeutics Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Compare $DWTX vs $HRGN

Comparing Dogwood Therapeutics Inc and Harvard Apparatus Regenerative Technology Inc

DWTXDogwood Therapeutics Inc

HRGNHarvard Apparatus Regenerative Technology Inc

DWTXDogwood Therapeutics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.0%

52W performance

-78.1%

FCF yield

-32.1%

HRGNHarvard Apparatus Regenerative Technology Inc

Market cap

$40M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

44.6%

YTD performance

16.2%

52W performance

-15.8%

FCF yield

-9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DWTX

HRGN

Detailed metrics comparison

DWTX

Dogwood Therapeutics Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

DWTX$47M

HRGN$40M

Enterprise Value

DWTX$37M

HRGN$41M

Price

DWTX$1.40

HRGN$2.30

P/E Ratio

DWTXN/A

HRGNN/A

P/S Ratio

DWTX0.00x

HRGN41.18x

EV/Sales

DWTX0.00x

HRGN41.33x

EV/EBITDA

DWTX0.00x

HRGN0.00x

P/B Ratio

DWTX0.73x

HRGN507.11x

P/FCF Ratio

DWTXN/A

HRGNN/A

EV/FCF

DWTX-2.48x

HRGN-11.16x

PEG Ratio

DWTXN/A

HRGNN/A

Forward P/E (NTM)

DWTXN/A

HRGNN/A

Forward P/S (NTM)

DWTXN/A

HRGNN/A

Revenue (TTM)

DWTX$0

HRGN$982K

Revenue Growth (YoY)

DWTXN/A

HRGN44.6%

Forward Rev Growth

DWTX613.9%

HRGN0.0%

Gross Margin (TTM)

DWTX0.0%

HRGN7.5%

Operating Margin (TTM)

DWTX0.0%

HRGN0.0%

EBITDA Margin (TTM)

DWTX0.0%

HRGN-682.9%

Net Margin (TTM)

DWTX0.0%

HRGN-680.5%

FCF Margin (TTM)

DWTXN/A

HRGN-370.2%

Net Income (TTM)

DWTX$-25M

HRGN$-7M

FCF (TTM)

DWTX$-15M

HRGN$-4M

EPS (TTM)

DWTX$0.00

HRGN-$0.38

ROE (TTM)

DWTX-3591.0%

HRGN-78637.0%

ROA (TTM)

DWTX-3028.0%

HRGN-30701.0%

ROIC (TTM)

DWTX-3591.0%

HRGN-77233.0%

Cash

DWTX$10M

HRGN$351K

Debt

DWTX$0

HRGN$500K

Net Cash/Debt

DWTX$10M

HRGN$-149K

Current Ratio (TTM)

DWTX3.89x

HRGN0.26x

Quick Ratio (TTM)

DWTX3.41x

HRGN0.12x

Debt/Equity (TTM)

DWTX0.00x

HRGN0.00x

Debt/Assets (TTM)

DWTX0.0%

HRGN0.0%

Interest Coverage (TTM)

DWTXN/A

HRGNN/A

Net Debt/EBITDA (TTM)

DWTX0.00x

HRGN0.00x

Beta

DWTX2.14

HRGN-0.50

52W Performance

DWTX-78.1%

HRGN-15.8%

YTD Performance

DWTX-67.0%

HRGN16.2%

% from 52W High

DWTX-80.1%

HRGN-21.2%

% from 52W Low

DWTX9.4%

HRGN145.8%

Asset Turnover (TTM)

DWTX0.00x

HRGN0.45x

FCF Yield (TTM)

DWTX-32.1%

HRGN-9.0%

Earnings Yield (TTM)

DWTX-52.1%

HRGN-16.5%

Dividend Yield (TTM)

DWTXN/A

HRGNN/A

Rule of 40

DWTX0.0

HRGN-325.5

EV/GP/RG

DWTXN/A

HRGNN/A

Ticker research

View DWTX research View HRGN research

Metric	DWTX Dogwood Therapeutics Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$47M	$40M
Enterprise Value	$37M	$41M
Price	$1.40	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	41.18x
EV/Sales	0.00x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.73x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.48x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$982K
Revenue Growth (YoY)	N/A	44.6%
Forward Rev Growth	613.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-682.9%
Net Margin (TTM)	0.0%	-680.5%
FCF Margin (TTM)	N/A	-370.2%
Net Income (TTM)	$-25M	$-7M
FCF (TTM)	$-15M	$-4M
EPS (TTM)	$0.00	-$0.38
ROE (TTM)	-3591.0%	-78637.0%
ROA (TTM)	-3028.0%	-30701.0%
ROIC (TTM)	-3591.0%	-77233.0%
Financial Health
Cash	$10M	$351K
Debt	$0	$500K
Net Cash/Debt	$10M	$-149K
Current Ratio (TTM)	3.89x	0.26x
Quick Ratio (TTM)	3.41x	0.12x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.14	-0.50
52W Performance	-78.1%	-15.8%
YTD Performance	-67.0%	16.2%
% from 52W High	-80.1%	-21.2%
% from 52W Low	9.4%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-32.1%	-9.0%
Earnings Yield (TTM)	-52.1%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View DWTX research	View HRGN research

Valuation

P/S Ratio

DWTX

0.00x

HRGN

41.18x

EV/FCF

HRGN

-11.16x

DWTX

-2.48x

Growth & revenue

Revenue Growth TTM

HRGN

44.6%

Forward Revenue Growth

DWTX

613.9%

HRGN

0.0%

Profitability & performance

Gross Margin

HRGN

7.5%

DWTX

0.0%

ROE

DWTX

-3591.0%

HRGN

-78637.0%

FCF Yield %

HRGN

-9.0%

DWTX

-32.1%

52-Week Performance

HRGN

-15.8%

DWTX

-78.1%

Detailed metrics comparison

DWTX

Dogwood Therapeutics Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

DWTX$47M

HRGN$40M

Enterprise Value

DWTX$37M

HRGN$41M

Price

DWTX$1.40

HRGN$2.30

P/E Ratio

DWTXN/A

HRGNN/A

P/S Ratio

DWTX0.00x

HRGN41.18x

EV/Sales

DWTX0.00x

HRGN41.33x

EV/EBITDA

DWTX0.00x

HRGN0.00x

P/B Ratio

DWTX0.73x

HRGN507.11x

P/FCF Ratio

DWTXN/A

HRGNN/A

EV/FCF

DWTX-2.48x

HRGN-11.16x

PEG Ratio

DWTXN/A

HRGNN/A

Forward P/E (NTM)

DWTXN/A

HRGNN/A

Forward P/S (NTM)

DWTXN/A

HRGNN/A

Revenue (TTM)

DWTX$0

HRGN$982K

Revenue Growth (YoY)

DWTXN/A

HRGN44.6%

Forward Rev Growth

DWTX613.9%

HRGN0.0%

Gross Margin (TTM)

DWTX0.0%

HRGN7.5%

Operating Margin (TTM)

DWTX0.0%

HRGN0.0%

EBITDA Margin (TTM)

DWTX0.0%

HRGN-682.9%

Net Margin (TTM)

DWTX0.0%

HRGN-680.5%

FCF Margin (TTM)

DWTXN/A

HRGN-370.2%

Net Income (TTM)

DWTX$-25M

HRGN$-7M

FCF (TTM)

DWTX$-15M

HRGN$-4M

EPS (TTM)

DWTX$0.00

HRGN-$0.38

ROE (TTM)

DWTX-3591.0%

HRGN-78637.0%

ROA (TTM)

DWTX-3028.0%

HRGN-30701.0%

ROIC (TTM)

DWTX-3591.0%

HRGN-77233.0%

Cash

DWTX$10M

HRGN$351K

Debt

DWTX$0

HRGN$500K

Net Cash/Debt

DWTX$10M

HRGN$-149K

Current Ratio (TTM)

DWTX3.89x

HRGN0.26x

Quick Ratio (TTM)

DWTX3.41x

HRGN0.12x

Debt/Equity (TTM)

DWTX0.00x

HRGN0.00x

Debt/Assets (TTM)

DWTX0.0%

HRGN0.0%

Interest Coverage (TTM)

DWTXN/A

HRGNN/A

Net Debt/EBITDA (TTM)

DWTX0.00x

HRGN0.00x

Beta

DWTX2.14

HRGN-0.50

52W Performance

DWTX-78.1%

HRGN-15.8%

YTD Performance

DWTX-67.0%

HRGN16.2%

% from 52W High

DWTX-80.1%

HRGN-21.2%

% from 52W Low

DWTX9.4%

HRGN145.8%

Asset Turnover (TTM)

DWTX0.00x

HRGN0.45x

FCF Yield (TTM)

DWTX-32.1%

HRGN-9.0%

Earnings Yield (TTM)

DWTX-52.1%

HRGN-16.5%

Dividend Yield (TTM)

DWTXN/A

HRGNN/A

Rule of 40

DWTX0.0

HRGN-325.5

EV/GP/RG

DWTXN/A

HRGNN/A

Ticker research

View DWTX research View HRGN research

Metric	DWTX Dogwood Therapeutics Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$47M	$40M
Enterprise Value	$37M	$41M
Price	$1.40	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	41.18x
EV/Sales	0.00x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.73x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.48x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$982K
Revenue Growth (YoY)	N/A	44.6%
Forward Rev Growth	613.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-682.9%
Net Margin (TTM)	0.0%	-680.5%
FCF Margin (TTM)	N/A	-370.2%
Net Income (TTM)	$-25M	$-7M
FCF (TTM)	$-15M	$-4M
EPS (TTM)	$0.00	-$0.38
ROE (TTM)	-3591.0%	-78637.0%
ROA (TTM)	-3028.0%	-30701.0%
ROIC (TTM)	-3591.0%	-77233.0%
Financial Health
Cash	$10M	$351K
Debt	$0	$500K
Net Cash/Debt	$10M	$-149K
Current Ratio (TTM)	3.89x	0.26x
Quick Ratio (TTM)	3.41x	0.12x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.14	-0.50
52W Performance	-78.1%	-15.8%
YTD Performance	-67.0%	16.2%
% from 52W High	-80.1%	-21.2%
% from 52W Low	9.4%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-32.1%	-9.0%
Earnings Yield (TTM)	-52.1%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View DWTX research	View HRGN research